Medroxyprogesterone Therapy for Sexual Precocity in Girls

Peter A. Lee

Research output: Contribution to journalArticlepeer-review

62 Scopus citations


An evaluation of 13 girls who had been treated intramuscularly with medroxyprogesterone acetate for sexual precocity showed that this drug has no effect on growth, skeletal maturation, or adult height. During treatment (mean duration, 3.6 years), menstruation was suppressed and breast size initially regressed, but breast development and pubic hair development progressed during long-term therapy. The extent of delay in resumption of menses after cessation of therapy was related both to duration of treatment and dosage of the drug.

Original languageEnglish (US)
Pages (from-to)443-445
Number of pages3
JournalAmerican Journal of Diseases of Children
Issue number5
StatePublished - May 1981

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Medroxyprogesterone Therapy for Sexual Precocity in Girls'. Together they form a unique fingerprint.

Cite this